Gene-gene interaction between tuberculosis candidate genes in a South African population.
In a complex disease such as tuberculosis (TB) it is increasingly evident that gene-gene interactions play a far more important role in an individual's susceptibility to develop the disease than single polymorphisms on their own, as one gene can enhance or hinder the expression of another gene. Gene-gene interaction analysis is a new approach to elucidate susceptibility to TB. The possibility of gene-gene interactions was assessed, focusing on 11 polymorphisms in nine genes (DC-SIGN, IFN-γ, IFNGR1, IL-8, IL-1Ra, MBL, NRAMP1, RANTES, and SP-D) that have been associated with TB, some repeatedly. An optimal model, which best describes and predicts TB case-control status, was constructed. Significant interactions were detected between eight pairs of variants. The models fitted the observed data extremely well, with p < 0.0001 for all eight models. A highly significant interaction was detected between INFGR1 and NRAMP1, which is not surprising because macrophage activation is greatly enhanced by IFN-γ and IFN-γ response elements that are present in the human NRAMP1 promoter region, providing further evidence for their interaction. This study enabled us to test the theory that disease outcome may be due to interaction of several gene effects. With eight instances of statistically significant gene-gene interactions, the importance of epistasis is clearly identifiable in this study. Methods for studying gene-gene interactions are based on a multilocus and multigene approach, consistent with the nature of complex-trait diseases, and may provide the paradigm for future genetic studies of TB.
de Wit
Erika
E
Molecular Biology and Human Genetics, MRC Centre for Molecular and Cellular Biology and the DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health Sciences, Stellenbosch University, Tygerberg 7505, South Africa.
van der Merwe
Lize
L
van Helden
Paul D
PD
Hoal
Eileen G
EG
D000328:Adult; D044383:Black People / Q000235:genetics*; D016022:Case-Control Studies; D004843:Epistasis, Genetic; D005260:Female; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D013019:South Africa / Q000453:epidemiology; D014376:Tuberculosis / Q000453:epidemiology / Q000208:ethnology / Q000235:genetics*
J Leukoc Biol. 2005 Apr;77(4):579-85
15629882
J Leukoc Biol. 1998 Jun;63(6):658-64
9620656
Hum Genet. 2008 Jun;123(5):477-84
18414898
J Infect Dis. 2003 Aug 1;188(3):349-55
12870115
Genes Immun. 2005 Jun;6(4):358-63
15815688
PLoS Genet. 2009 Jul;5(7):e1000540
19584936
Genes Immun. 2004 Aug;5(5):381-8
15164102
Am J Hum Genet. 2001 Jul;69(1):138-47
11404819
Mol Immunol. 2006 Jul;43(14):2143-50
16500704
Genes Immun. 2007 Sep;8(6):475-9
17625600
Nat Rev Genet. 2009 Jun;10(6):392-404
19434077
Int J Tuberc Lung Dis. 2009 Sep;13(9):1068-76
19723394
PLoS Med. 2006 Feb;3(2):e20
16379498
N Engl J Med. 2000 Jul 13;343(2):108-17
10891520
Am Rev Respir Dis. 1978 Apr;117(4):621-4
565607
Neurosci Lett. 2004 Aug 19;366(3):326-31
15288444
Pediatr Res. 1999 Apr;45(4 Pt 1):459-64
10203135
Indian J Med Res. 2006 Oct;124(4):403-10
17159260
Tuber Lung Dis. 1998;79(2):83-9
10645445
Lancet. 2003 May 31;361(9372):1871-2
12788577
Proc Natl Acad Sci U S A. 2005 Aug 23;102(34):12183-8
16103355
J Infect Dis. 2000 Nov;182(5):1473-8
11023470
Int J Tuberc Lung Dis. 2004 Dec;8(12):1464-71
15636493
Lancet. 2007 Dec 15;370(9604):2030-43
17719083
Mem Inst Oswaldo Cruz. 2006 Nov;101(7):697-714
17160276
J Exp Med. 2003 Jan 6;197(1):7-17
12515809
Annu Rev Immunol. 2003;21:547-78
12524383
Tuberculosis (Edinb). 2006 Nov;86(6):419-29
16730231
N Engl J Med. 1988 Mar 24;318(12):727-32
3347221
Hum Genet. 2010 Aug;128(2):145-53
20490549
Trends Microbiol. 2003 Jun;11(6):259-63
12823942
Hum Genet. 1993 May;91(4):403-4
8500797
Am J Respir Crit Care Med. 2006 Aug 1;174(3):339-43
16690980
C R Biol. 2005 Jul;328(7):606-15
15992744
Dis Markers. 1999 Dec;15(4):269-81
10689550
Scand J Immunol. 2006 Feb;63(2):142-50
16476014
BMJ. 1998 Apr 18;316(7139):1236-8
9553006
J Hum Genet. 2006;51(12):1055-1062
17006604
N Engl J Med. 1998 Mar 5;338(10):640-4
9486992
Autoimmunity. 2006 Dec;39(8):691-704
17178566
Mol Immunol. 2005 Feb;42(2):145-52
15488604
J Immunol Methods. 2003 May 1;276(1-2):147-9
12738368
Hum Genet. 2009 Nov;126(5):643-53
19575238
Am J Obstet Gynecol. 2006 Nov;195(5):1249-53
17074546
Am J Hum Genet. 2004 Apr;74(4):765-9
14997420
Hypertension. 2000 Jul;36(1):2-6
10904004
Clin Exp Allergy. 2004 Aug;34(8):1202-8
15298559
J Infect Dis. 2001 Nov 1;184(9):1152-62
11598838
Thorax. 2004 Apr;59(4):291-4
15047947
J Exp Med. 1993 Dec 1;178(6):2243-7
8245795
J Infect Dis. 2002 Nov 15;186(10):1463-8
12404162
Lancet. 1998 Dec 12;352(9144):1886-91
9863786
Int J Tuberc Lung Dis. 2003 Mar;7(3):271-7
12661843
Hum Mol Genet. 2003 Oct 15;12(20):2599-608
12925570
Ann Rheum Dis. 2006 Sep;65(9):1188-91
16476711
Hypertension. 2003 Jan;41(1):9-15
12511523
Int J Tuberc Lung Dis. 2004 Apr;8(4):428-34
15141734
Int J Tuberc Lung Dis. 2006 Jan;10(1):3-12
16466030
Lancet. 2004 Dec 11-17;364(9451):2113-21
15589309
Clin Infect Dis. 2002 Jan 15;34(2):204-9
11740709
J Med Genet. 1999 Apr;36(4):295-9
10227396
J Immunol. 1995 Sep 15;155(6):3013-20
7673719
BMC Syst Biol. 2008 Apr 23;2:36
18433497
J Infect Dis. 2003 Sep 1;188(5):777-82
12934195
Am J Hum Genet. 2010 Apr 9;86(4):611-20
20346436
Tuberculosis (Edinb). 2010 Mar;90(2):71-83
20206579
Mol Immunol. 2003 Nov;40(7):423-9
14568388
Am J Respir Crit Care Med. 2003 Apr 1;167(7):970-5
12531774